The 2nd World Conference of Immuno-Oncology-2019 (WCIO-2019)

Scientific Program

Stream 1: Keynote Forum
Day 1: Morning, Friday, October 11, 2019 Place: Room 617 & 618, 6th Floor, Dalian International Conference Center
Moderator: Dr. Qun Dang, Corporate Vice President, CSPC PHARMA LTD, China
Time	Speeches and Speakers
10:00-10:05	Moderator's Introduction
10:05-10:30	Title: Anti-PD-1 Antibody Function Impacted by Tumor-associated Macrophages Dr. Kang Li, SVP, Head of Biologics, BeiGene, China
10:30-10:55	Title: Versatile Dendritic Nanoparticles for Immunotherapy and Biomarker Development Dr. Seungpyo Hong, Professor, Pharmaceutical Sciences Division, School of Pharmacy, University of Wisconsin - Madison, USA
10:55-11:20	Title: SMAB, An Innovative Bispecific Antibody Format Dr. Yi Jin, Senior Director of Research and Discovery, GenScript Biotech Corp., China
11:20-11:45	Title: IO Therapy beyond PD-1 and T Cells? Dr. Qun Dang, Corporate Vice President, CSPC PHARMA LTD, China
11:45-12:10	Title: Targeting C5a in Oncoimmunology Dr. Renfeng Guo, CSO and Founder, InflaRx Pharmaceuticals Inc., USA